Congenital Heart Disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) infants and neonates undergoing cardiac surgeries with cardiopulmonary bypass in our institution And 2) written informed consent is obtained from a parent of each patient.
Exclusion criteria
Exclusion criteria: 1) cases of written informed consent not obtained from the parent of the patient Or 2) cases of modified ultrafiltration not performed following cessation of the cardiopoumonary bypass Or 3) cases of modified ultrafiltration interrupted with second pump run
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) arterial blood gas, platelet count, and plasma concentration of fibrinogen at cessation of transfusion of plateles and fresh frozen plasma during MUF | — |
Secondary
| Measure | Time frame |
|---|---|
| 2) fibrinogen concentration in the blood at cessation of transfusion of fresh frozen plasma during MUF 3) blood loss and the total amount of transfusion follwing cessation of the cardiopulmonary bypass 4) arterial blood gas, platelet count, and plasma concentration of fibrinogen on the time point of admission in the postoperative care unit | — |
Countries
Japan
Contacts
Gifu Prefectural General Medical Center Department of Anesthesiology